Traders should monitor for official pricing and initial trading activity, which could see strong demand given the company's high revenue growth and positioning in the advanced proteomics market. Early secondary market indications may signal pricing strength.
Price Chart
Executive Summary
Alamar Biosciences' IPO registration has become effective, allowing the company to begin selling shares to the public. The offering is expected to price soon, with shares set to trade on Nasdaq under ticker ALMR.
Key Facts
- IPO registration (Form S-1) has become effective as of April 16, 2026
- Company is set to begin public trading on Nasdaq under symbol ALMR
- Offering expected to price imminently, with shares delivered around late April 2026
- Proceeds will be used for R&D, commercial expansion, and general corporate purposes
- Company reported $74.2M in 2025 revenue, up 196% YoY, driven by proteomics platform adoption
Financial Impact
Capital raise undetermined pending final pricing, but expected to provide significant funding for growth; 2025 revenue was $74.2M with 196% YoY growth
Risk Factors
- Execution risk in post-IPO share performance, common to newly listed growth companies
- Dilution from future share issuances under shelf capacity post-listing
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001218 |
| Document: 9999999995-26-001218-index.html | 9999999995-26-001218 |
| Document: 9999999995-26-001218.txt | 9999999995-26-001218 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 12d ago | 144 | $27.42 | awaiting T+60 | — | $30.39 (−10.83%) |
Oct 14, 2026 12d ago | 144 | $27.42 | awaiting T+60 | — | $30.39 (−10.83%) |
Oct 14, 2026 12d ago | 144 | $27.42 | awaiting T+60 | — | $30.39 (+10.83%) |
Oct 5, 2026 21d ago | Press Release | $32.26 | awaiting T+60 | — | $30.39 (−5.80%) |
Sep 24, 2026 4w ago | Press Release | $32.80 | awaiting T+60 | — | $30.39 (−7.35%) |
Sep 1, 2026 7w ago | 8-K | $30.49 | awaiting T+60 | — | $30.39 (−0.33%) |
Aug 10, 2026 11w ago | 8-K | $36.57 | awaiting T+60 | — | $30.39 (−16.90%) |
Jul 13, 2026 15w ago | Press Release | $27.40 $32.26 | ▲ +17.74% | ▲ +13.74% | $30.39 (+10.91%) |
Jul 10, 2026 15w ago | Press Release | $28.42 $38.13 | ▲ +34.17% | ▲ +31.53% | $30.39 (+6.93%) |
May 8, 2026 24w ago | 8-K | $23.96 $27.11 | ▲ +13.15% | ▲ +8.31% | $30.39 (+26.84%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers